A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis.

about

A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis.

Item

http://www.wikidata.org/entity/Q47773146

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A Novel Aza-MBP Altered Peptid ...... Autoimmune Encephalomyelitis.

@en

A Novel Aza-MBP Altered Peptid ...... Autoimmune Encephalomyelitis.

@nl

type

Item

label

A Novel Aza-MBP Altered Peptid ...... Autoimmune Encephalomyelitis.

@en

A Novel Aza-MBP Altered Peptid ...... Autoimmune Encephalomyelitis.

@nl

prefLabel

A Novel Aza-MBP Altered Peptid ...... Autoimmune Encephalomyelitis.

@en

A Novel Aza-MBP Altered Peptid ...... Autoimmune Encephalomyelitis.

@nl

P1476

A Novel Aza-MBP Altered Peptid ...... Autoimmune Encephalomyelitis.

@en

P2093

Azizul Haque

http://www.w3.org/2001/XMLSchema#string

Craig C Beeson

http://www.w3.org/2001/XMLSchema#string

Jennifer Harmon

http://www.w3.org/2001/XMLSchema#string

Jonathan T Butler

http://www.w3.org/2001/XMLSchema#string

Joshua Mount

http://www.w3.org/2001/XMLSchema#string

Naren L Banik

http://www.w3.org/2001/XMLSchema#string

Nicole N M Trager

http://www.w3.org/2001/XMLSchema#string

P2860

Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au

STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.

Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.

Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production

Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft.

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.

T-cell activation through immunological synapses and kinapses.

Vaccines for multiple sclerosis: progress to date.

Antigen-specific therapies in MS - Current concepts and novel approaches.

Bioactive peptides, networks and systems biology.

P2888

s12035-017-0739-4

P304

267-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-017-0739-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Podbielska

P577

2017-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28889362

http://www.w3.org/2001/XMLSchema#string

P932

5808857

http://www.w3.org/2001/XMLSchema#string